Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933489 · ClinicalTrials.gov registry record · NA
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts
A NA study of Asymptomatic, sponsored by ECOG-ACRIN Cancer Research Group.
- Active
- Registry status
- NA
- Development phase
- 1,516
- Enrollment target
- 20
- Study locations
NCT02933489 is a NA study of Asymptomatic that is active but no longer recruiting, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 1,516 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT02933489, a NA study of Asymptomatic, is active but no longer recruiting, sponsored by ECOG-ACRIN Cancer Research Group.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,516 participants
- Enrollment target
- 20
- Study locations
Study Summary
This randomized phase II trial studies how well abbreviated breast magnetic resonance imaging (MRI) and digital tomosynthesis mammography work in detecting cancer in women with dense breasts. Abbreviated breast MRI is a low cost procedure in which radio waves and a powerful magnet linked to a computer and used to create detailed pictures of the breast in less than 10 minutes. These pictures can show the difference between normal and diseased tissue. Digital tomosynthesis mammography is a procedure that uses multiple x-rays pictures of each breast to produce a 3-dimensional rendering of the entire breast. Combined screening with abbreviated breast MRI and digital tomosynthesis mammography may be a better method to screen women with dense breasts.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- DIAGNOSTIC_TEST Contrast-enhanced Magnetic Resonance Imaging
- DIAGNOSTIC_TEST Digital Tomosynthesis Mammography
Study Locations (20)
Illinois
- Northwestern University - Chicago
- University of Chicago Comprehensive Cancer Center - Chicago
- NorthShore University HealthSystem-Evanston Hospital - Evanston
- Clinical Radiologists SC - Springfield
Florida
- Boca Raton Regional Hospital - Boca Raton
- Mayo Clinic in Florida - Jacksonville
- Diagnostic Center for Women LLC - Miami
Colorado
- The Women's Imaging Center - Denver
- Radiology Imaging Associates - Englewood
Indiana
- Indiana University/Melvin and Bren Simon Cancer Center - Indianapolis
- The Community Hospital - Munster
Kansas
- University of Kansas Cancer Center - Kansas City
- University of Kansas Hospital-Westwood Cancer Center - Westwood
Arizona
- Banner MD Anderson Cancer Center - Gilbert
California
- Huntington Memorial Hospital - Pasadena
Connecticut
- Norwalk Hospital - Norwalk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,516 participants |
| Start Date | 2016-12-27 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02933489
The ClinicalTrials.gov registry entry for NCT02933489 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,516 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asymptomatic appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT02933489 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Illinois, Florida, Colorado.
Frequently Asked Questions
What is clinical trial NCT02933489 about?
NCT02933489 is a clinical study titled "Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts". This randomized phase II trial studies how well abbreviated breast magnetic resonance imaging (MRI) and digital tomosynthesis mammography work in detecting cancer in women with dense breasts. Abbreviated breast MRI is a low cost procedure in which radio waves and a powerful magnet linked to a comput...
What is the current status of trial NCT02933489?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,516 participants. The study started on 2016-12-27. Estimated completion is 2026-12-31.
What conditions does trial NCT02933489 study?
This clinical trial studies the following conditions: Asymptomatic.
What interventions are being tested in trial NCT02933489?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Contrast-enhanced Magnetic Resonance Imaging (DIAGNOSTIC_TEST), Digital Tomosynthesis Mammography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02933489?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02933489 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.